Revive Therapeutics (XCNQ:RVV) Net Change in Cash : C$-1.38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Revive Therapeutics's Net Change in Cash for the three months ended in Dec. 2023 was C$-0.88 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 was C$-1.38 Mil.

Revive Therapeutics Net Change in Cash Historical Data

The historical data trend for Revive Therapeutics's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Net Change in Cash Chart

Revive Therapeutics Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Net Change in Cash

Get a 7-Day Free Trial

-0.59

0.91

15.22

-12.68

-1.83

Revive Therapeutics Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Sep23	Dec23
Net Change in Cash	Get a 7-Day Free Trial															-2.33	-0.88	-	-0.50	-0.88

Revive Therapeutics Net Change in Cash Calculation

Revive Therapeutics's Net Change in Cash for the fiscal year that ended in Jun. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-6.026	+	0	+	4.198	+	0
	=	-1.83

Revive Therapeutics's Net Change in Cash for the quarter that ended in Dec. 2023

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -0.883 + 0 + 0 + 0

= -0.88

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-1.38 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Revive Therapeutics Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Revive Therapeutics's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Revive Therapeutics (XCNQ:RVV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Net Change in Cash

Comparable Companies

TSX:WLLW XCNQ:SLNG TSXV:NDVA XCNQ:IMCC TSX:CTX XCNQ:STHZ XCNQ:OILS XCNQ:XTRX TSX:VPH XCNQ:CANN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692

Traded in Other Exchanges

RVVTF:USA 31R:Germany

Address

82 Richmond Street East, Toronto, ON, CAN, M5C 1P1

Website

https://www.revivethera.com

Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care.

Executives

Michael Frank Director, Senior Officer

Revive Therapeutics (XCNQ:RVV) Headlines

No Headlines